Fyodor Biotechnologies

company

About

Fyodor Biotechnologies is a medical device company.

  • 1 - 10

Details

Last Funding Type
Seed
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active

Fyodor is a privately held medical device company whose mission is to develop and commercialize novel medical diagnostic tests that address unmet needs in Nigeria and emerging economies. In response to the large proportion of malaria that is managed at home and in all healthcare settings, Fyodor has developed the Urine Malaria TestTM (UMT) – the first ever non-blood (one-step, no blood, no reagents, no equipment, visually read) rapid test that tells in 25 minutes or less if a fever is due to malaria or not. It removes the complexity, pain and risks associated with a blood test.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$1.46M
Fyodor Biotechnologies has raised a total of $1.46M in funding over 2 rounds. Their latest funding was raised on Jul 24, 2018 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 24, 2018 Seed 1 Detail
May 16, 2018 Seed 1 Detail
Sep 9, 2013 Grant $729.78K 1 National Science Foundation Detail
Aug 14, 2012 Grant $571.43K 1 National Science Foundation Detail
Jun 13, 2012 Grant $165K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
3
3
Fyodor Biotechnologies is funded by 3 investors. National Science Foundation and The Investment Collective are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
The Investment Collective Seed
500 Global Seed